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Mammalian genomes encode two related serine-threonine kinases, nuclear Dbf2 related (NDR)1 and NDR2, which are homologous to the
Saccharomyces cerevisiae Dbf2 kinase. Recently, a yeast genetic screen implicated the Dbf2 kinase in Ty1 retrotransposition. Since several
virion-incorporated kinases regulate the infectivity of human immunodeficiency virus type 1 (HIV-1), we speculated that the human NDR1
and NDR2 kinases might play a role in the HIV-1 life cycle. Here we show that the NDR1 and NDR2 kinases were incorporated into HIV-1
particles. Furthermore, NDR1 and NDR2 were cleaved by the HIV-1 protease (PR), both within virions and within producer cells. Truncation
at the PR cleavage site altered NDR2 subcellular localization and inhibited NDR1 and NDR2 enzymatic activity. These studies identify two
new virion-associated host cell enzymes and suggest a novel mechanism by which HIV-1 alters the intracellular environment of human cells.
D 2004 Elsevier Inc. All rights reserved.
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The nuclear Dbf2-related (NDR) kinases encompass a
conserved subclass of the protein kinases A, G, and C
(AGC) group of kinases (Tamaskovic et al., 2003a). Ma-
mmalian genomes encode two highly related serine-threo-
nine kinases, NDR1 and NDR2, which are approximately
87% identical at the amino acid level. Human NDR1 was0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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homologous to the Saccharomyces cerevisiae Dbf2 kinase
(Millward et al., 1995). NDR1 and NDR2 mRNAs are
ubiquitously expressed in human tissues (Devroe et al.,
2004; Millward et al., 1995; Stegert et al., 2004), and NDR1
mRNA is particularly abundant in peripheral blood leuko-
cytes (Millward et al., 1995). In contrast to the nuclear
distribution exhibited by NDR1, NDR2 is mostly excluded
from the nucleus and exhibits a punctate cytoplasmic
distribution (Devroe et al., 2004; Stegert et al., 2004; Stork
et al., 2004).
Recent studies have indicated the human NDR kinases
are regulated via interactions with at least two different
human Mob proteins (Bichsel et al., 2004; Devroe et al.,
2004). Mob proteins were first identified as kinase activat-
ing subunits in yeast (Luca and Winey, 1998), and S.
cerevisiae Mob1 has been shown to bind to and regulate
Dbf2 catalytic activity (Komarnitsky et al., 1998; Mah et al.,
2001). In addition, S. cerevisiae Mob2 has been shown to05) 181–189
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the NDR family of kinases (reviewed in Tamaskovic et al.,
2003a). Thus, Mob regulation of the NDR kinases is
conserved from yeast to humans.
To date, the budding yeast Cbk1 kinase has been
implicated in the maintenance of polarized growth, while
the Dbf2 kinase has been linked to the regulation of the
mitotic exit network (reviewed in Tamaskovic et al., 2003a).
The function(s) of mammalian NDR1 and NDR2 has not
been established. However, a recent report suggests that the
murine NDR2 kinase associates with the actin cytoskeleton
and may play an important role in neuronal growth and
differentiation (Stork et al., 2004). Given that Mob regu-
lation of the budding yeast NDR kinases is conserved in
humans, the functions of the NDR1 and NDR2 kinases may
emulate those of Dbf2 or Cbk1. Recently, a screen was
performed to identify nonessential host factors that affect the
life cycle of the S. cerevisiae Ty1 retrotransposon. Interest-
ingly, this analysis determined that S. cerevisiae strains
containing a DBF2 gene deletion exhibit an 8-fold defect in
Ty1 retrotransposition (Griffith et al., 2003). Since retro-
transposons and retroviruses share many features in their life
cycles, including reverse transcription, integration, and the
formation of ribonucleoprotein particles (Coffin et al., 1997),
we hypothesized that human NDR1 and NDR2 kinases
might participate in HIV-1 replication.
HIV-1 particles have been shown to incorporate at least
three cellular serine-threonine kinases, ERK2/MAPK (Cartier
et al., 1997; Jacque et al., 1998), the catalytic subunit of
cAMP-dependent protein kinase (C-PKA) (Cartier et al.,
2003), and an unidentified ~53 kDa kinase (Cartier et al.,
1997, 1999). ERK2/MAPK has been shown to phosphorylate
the viral matrix protein and modulate HIV-1 infectivity by as
much as 4-fold (Jacque et al., 1998) and to phosphorylate the
viral p6gag protein, which effects viral assembly and release
(Hemonnot et al., 2004). C-PKAwas also shown to regulate
HIV-1 infectivity, possibly via phosphorylation of the viral
capsid (CA) protein (Cartier et al., 2003). Given that the
calculated molecular masses of NDR1 and NDR2 are ~54
kDa, we considered that the unidentified ~53 kDa kinase
might be NDR1 or NDR2. Here we show that NDR1 and
NDR2 are indeed incorporated into HIV-1 particles and are
processed by the viral protease (PR).Results
NDR1 kinase incorporation into HIV-1 particles
To test the hypothesis that the NDR1 and NDR2 kinases
might be incorporated into HIV-1 particles, we began by
performing Western blot analysis of sucrose gradient-
purified HIV-1IIIB using an anti-NDR1 monoclonal anti-
body. NDR1 was readily detected in sucrose gradient-
purified HIV-1 particles (Fig. 1A). Unfortunately, such viral
preparations are frequently contaminated with cellularmicrovesicles possessing similar densities as retroviral
particles, a fact that significantly complicates identification
of virion-incorporated proteins (Bess et al., 1997; Gluschan-
kof et al., 1997). However, these cellular contaminants can
be efficiently removed following digestion with the sub-
tilisin protease and subsequent centrifugation through a
sucrose cushion to sediment protease-resistant HIV-1 cores
away from proteolyzed microvesicles (Ott et al., 1995).
Under these conditions, internal HIV-1 proteins for the most
part resist protease digestion (Gurer et al., 2002; Ott et al.,
1995, 1996; Sova et al., 2001; Trubey et al., 2003). Thus,
digestion with subtilisin and subsequent pelleting through
sucrose both greatly reduce microvesicle contamination and
identify stoichiometrically recovered proteins as intravirion
(Ott et al., 1995).
To determine whether NDR1 was an HIV-associated
protein or a component of cellular microvesicles, we
digested sucrose gradient-purified HIV-1IIIB and HIV-1MN
with subtilisin. As a control, we confirmed that subtilisin-
digested virion preparations were free of CD45 (Fig. 1B), a
known abundant component of T-cell microvesicles (Esser
et al., 2001; Trubey et al., 2003). In contrast to CD45,
NDR1 was readily detected in HIV-1IIIB and HIV-1MN
following subtilisin digestion.
Although the above result argued that NDR1 was a bona
fide component of HIV-1 particles, we sought to confirm
NDR1 incorporation using an independent and more easily
controlled approach. Thus, we switched to a transient
transfection strategy to allow direct comparison of NDR1
recovery from control versus HIV-1-producing cells. Sub-
tilisin was used to digest sucrose-pelleted supernatants from
mock or HIV-1NL4-3 proviral DNA transfected 293Tcells. As
before, the protease digests were subsequently pelleted
through sucrose and analyzed by Western blotting. NDR1
was not detected in the supernatant from mock-transfected
cells (Fig. 1C), which indicates NDR1 is not a component of
293T cell microvesicles. However, NDR1 was readily
detected in HIV-1-containing supernatants (Fig. 1C). Fur-
thermore, NDR1, like internal HIV-1 proteins, was resistant
to subtilisin digestion (Fig. 1C). We note that 293T cells do
not express CD45 (data not shown), and therefore confirmed
that the external HIV-1 gp41 envelope protein was efficiently
degraded by subtilisin (Fig. 1C). Next, we reasoned that if
NDR1 was protected from subtilisin digestion due to its
presence within the HIV-1 core, it should be susceptible to
digestion following physical disruption of the virions. Thus,
we repeated the above experiment after first disrupting
virions with Nonidet P40 (NP-40). Under these conditions,
NDR1 was degraded, as were core viral proteins (Fig. 1D).
Taken together, these findings indicate that the NDR1 kinase
is a true component of HIV-1 particles.
NDR2 incorporation into HIV-1 particles
Next, we sought to determine whether the NDR1
homolog NDR2 was also incorporated into HIV-1. Anti-
Fig. 2. NDR2 can be incorporated into HIV-1 particles. 293T cells were
cotransfected with pFLAG-NDR1 or pFLAG-NDR2 and pNL43/XmaI
proviral DNA, and virus particles were pelleted through 20% sucrose.
NDR1 and NDR2 were detected in pelleted material only upon HIV-1 co-
expression. When cotransfected with HIV-1 proviral DNA, NDR1 and
NDR2 migrated as a doublet.
Fig. 1. NDR1 is incorporated into HIV-1 particles. (A) Western blot analysis of sucrose gradient-purified HIV-1IIIB. Extracts of uninfected HeLa cells serve as a
positive control. (B) Subtilisin digestion of T-cell-derived HIV-1 particles. Sucrose gradient-purified HIV-1IIIB and HIV-1MN were incubated in the presence or
absence of 500 Ag/ml subtilisin for 18 h at 37 8C. Whereas subtilisin removed cellular microvesicles as confirmed by anti-CD45 Western blotting, a significant
fraction of NDR1 resisted proteolysis. Extracts from Jurkat T-cells serve as a positive control for both Western blots. n/a, not applicable. (C) Sucrose-pelleted
virus from mock- or pNL43/XmaI-transfected 293T cells was incubated with the indicated final concentrations of subtilisin for 18 h at 37 8C. Whereas
subtilisin efficiently digested the surface-exposed gp41 envelope glycoprotein, NDR1 and CAwere completely resistant to proteolysis. (D) Subtilisin digestion
of disrupted virions. Sucrose-pelleted virus from pNL43/XmaI-transfected 293T cells was digested overnight at 37 8C in the presence (+) or absence () of 500
Ag/ml subtilisin following mock treatment () or disruption by three rounds of freezing and thawing in the presence of 0.5% NP-40 (+). Upon physical
disruption of the virions, NDR1 was digested by subtilisin, as were other internal virus proteins.
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therefore, we co-expressed FLAG epitope-tagged NDR2
(FLAG-NDR2) with HIV-1 in virus-producing cells. Since
the results presented in the previous section demonstrated
specific incorporation of endogenous NDR1 kinase into
HIV-1, FLAG-NDR1 was co-expressed with HIV-1 as a
comparative control. Consistent with our initial observations
with endogenous NDR1 (Fig. 1C), FLAG-NDR1 and
FLAG-NDR2 were detected in sucrose-pelleted cell super-
natants only upon HIV-1 co-expression (Fig. 2). Both
FLAG-NDR1 and FLAG-NDR2 were present in pelleted
viral preparations following subtilisin treatment (data not
shown).
Intriguingly, HIV-1 expression altered the electropho-
retic mobility of a fraction of NDR1 and NDR2 both
within virions and producer cell lysates (Fig. 2), suggest-
ing that HIV-1 might induce posttranslational modifica-
tion(s) to NDR1 and NDR2. We also noted that
endogenous NDR1 present within T-cell-derived HIV-1
migrated as multiple species (Figs. 1A and B). HIV-1
particles purified from transiently transfected 293T cells
contained a dominant form, although minor isoforms were
also observed in these preparations (Figs. 1C and D).
Given that NDR kinase activity is regulated by phosphor-
ylation (Devroe et al., 2004; Millward et al., 1999; Stegertet al., 2004; Tamaskovic et al., 2003b), we reasoned HIV-1
might influence the phosphorylation status of NDR1 and
NDR2. To determine whether faster migrating species
represented alternately phosphorylated forms of the NDR1
and NDR2 kinases, protein lysates containing FLAG-
tagged NDR1 and NDR2 were treated with calf intestinal
alkaline phosphatase (CIP) prior to Western blot analysis.
Although each band migrated slightly faster following CIP
treatment, CIP did not collapse the doublet into a single
Fig. 3. The HIV-1 PR proteolytically processes NDR1 and NDR2. (A) 293T
cells were cotransfected with pFLAG-NDR1 or pFLAG-NDR2 and the
indicated proviral DNAs, and cell extracts were analyzed by Western
blotting. The processed forms of NDR1 and NDR2 (arrowheads) were
observed upon cotransfection with WT HIV-1NL4-3 and HIV-1HXBX10 but
not following cotransfection with PR-deficient HIV-1HXBX10 proviral DNA
or a control plasmid. (B) Lysates from mock-transfected or HIV-1NL4-3
proviral DNA-transfected 293T cells were analyzed by anti-NDR1 Western
blotting. Endogenous NDR1 was processed (arrowhead) specifically
following HIV-1 expression. When indicated, transfections were performed
in the presence of 5 AM of the PR inhibitors Saquinavir or Nelfinavir, or an
equivalent volume of the diluent dimethyl sulfoxide (DMSO). (C) 293T
cells were transfected in the presence or absence of 5 AM Saquinavir with
pFLAG-NDR1 or pFLAG-NDR2 and HIV-1NL4-3 proviral DNA. Virus
particles were pelleted through 20% sucrose. Cell extracts and virion lysates
were analyzed by anti-FLAG Western blotting. Saquinavir inhibited
processing of FLAG-NDR1 and FLAG-NDR2 in both producer cells and
pelleted HIV-1 particles. Below, the polyvinylidine fluoridine membrane
used for the anti-FLAG Western blot was stained with Ponceau S. As
expected, processing of the p55gag precursor (**) into p24CA (*) was
inhibited in the presence of Saquinavir.
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NDR1 and NDR2 posttranslational modification that was
distinct from phosphorylation.
HIV-1 PR processing of the NDR1 and NDR2 kinases
We next considered the possibility that HIV-1 PR
proteolytically processed NDR1 and NDR2. To test this
idea, FLAG-NDR1 and FLAG-NDR2 were co-expressed in
293T cells with various proviral DNAs. Modification of
NDR1 and NDR2 was induced when the kinases were co-
expressed with wild-type (WT) HIV-1NL4-3 or HIV-
1HXBX10, but not a PR-deficient HIV-1HXBX10 strain (Fig.
3A). Thus, genetic evidence places the HIV-1 PR upstream
of FLAG-NDR1 and FLAG-NDR2 processing.
To determine whether endogenous NDR1 was similarly
processed, we examined endogenous NDR1 mobility in
293T cell lysates following mock transfection or trans-
fection with HIV-1NL4-3 proviral DNA. Consistent with our
initial studies using exogenously expressed FLAG-NDR1
and FLAG-NDR2 (Figs. 2 and 3A), nearly half of
endogenous NDR1 was likewise processed upon HIV-1
expression (Fig. 3B). Next, we examined endogenous
NDR1 processing following transfection of 293T cells with
HIV-1NL4-3 proviral DNA in the presence of Saquinavir or
Nelfinavir, two small molecule inhibitors of the HIV-1 PR.
Chemical inhibition of HIV-1 PR completely inhibited
processing of endogenous NDR1 in HIV-1 producer cell
lysates (Fig. 3B).
Finally, we sought to determine whether PR inhibition
affected incorporation of NDR1 and NDR2 into HIV-1
particles. Thus, we purified HIV-1 particles from the
supernatants of 293T cells expressing FLAG-NDR1 or
FLAG-NDR2 grown in the presence or absence of
Saquinavir. The nonprocessed NDR1 and NDR2 were
efficiently incorporated into HIV-1 particles (Fig. 3C),
which indicates that virion incorporation and proteolytic
processing of NDR1 and NDR2 are physically separable
events.
Functional significance of PR cleavage
Our above results demonstrated that NDR1 and NDR2
were processed in an HIV-1 PR-dependent manner, which
suggested that PR directly cleaved NDR1 and NDR2.
Although PR substrate specificity is not completely under-
stood, recent experimental and computational results have
highlighted several residues surrounding the scissile bond
that promote or inhibit cleavage (Beck et al., 2000;
Rognvaldsson and You, 2004). Based on current under-
standing of PR substrate specificity, we sought to identify a
PR cleavage site within NDR1 and NDR2. Since the N-
terminal FLAG epitope remained following PR cleavage
(Figs. 2 and 3), we reasoned the cleavage site must be
located near the NDR1 and NDR2 C-termini. Sequence
inspection identified an appropriately positioned candidatePR cleavage site (Fig. 4A), which contains highly favorable
Val, Phe, and Thr residues in the P2, P1, and P4V sites,
respectively (Beck et al., 2000; Rognvaldsson and You,
2004). Intriguingly, the candidate cleavage site is located at
the beginning of a hydrophobic motif conserved among
Fig. 4. Functional consequences of C-terminal truncation. (A) Identification of candidate PR cleavage sites near the NDR1 and NDR2 C-termini. The putative
scissile bond (PR) and Thr residue (Thr*) known to be important for regulating NDR1 (Tamaskovic et al., 2003a) and NDR2 (Stegert et al., 2004) activity are
highlighted by arrows. The PR-resistant (PRres) expression vectors were constructed by mutating the coding sequence of the underlined VF residues to KK. C-
terminally truncated expression (DC) vectors were constructed by inserting a stop codon (d ) following the indicated VF. (B) Western blot analysis of extracts
from 293T cells transfected with WT or PRres pFLAG-NDR1 or pFLAG-NDR2 with (+) or without () HIV-1NL4-3 proviral DNA. The PRres kinases, designed
to disrupt the putative HIV-1 PR cleavage site, were not processed upon co-expression of HIV-1. (C) Same as in B, except that DC constructs were analyzed.
The DC kinases comigrated with the PR-processed forms of NDR1 and NDR2. The DC kinases exhibited the same electrophoretic mobility upon co-expression
of HIV-1 (data not shown). (D) Subcellular localization of WT and DC kinases. HeLa-CD4 cells were transiently transfected with WT or DC pFLAG-NDR1 or
pFLAG-NDR2 expression vectors, and analyzed by indirect immunofluorescence microscopy. C-terminal truncation altered the subcellular distribution of
NDR2 but not NDR1. (E) Analysis of WT and DC kinase activity. Full-length and truncated FLAG-NDR1 and FLAG-NDR2 were co-expressed with GFP-
Mob2 and purified by anti-FLAG affinity purification. A mock purification () was performed with cells expressing only GFP-Mob2. Anti-FLAG Western
blotting confirms the expression and purification of each respective kinase, while anti-GFP Western blotting demonstrates that C-terminal truncation did not
inhibit GFP-Mob2 association. Kinase assays demonstrated that NDR1DC and NDR2DC retained autophosphorylation activity (auto-32P), but were severely
defective for transphosphorylation of myelin basic protein (MBP 32P). For transphosphorylation reactions, approximately three times more NDR1 was included
to compensate for the relatively low activity of NDR1 (Devroe et al., 2004). Mock transphosphorylation reactions () included myelin basic protein only.
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phosphoaccepting Thr residue (at the putative P4V site)
known to be important for NDR1 (Tamaskovic et al., 2003a)
and NDR2 kinase activity (Stegert et al., 2004).
To confirm the location of the PR cleavage site, FLAG-
NDR1 and FLAG-NDR2 expression vectors were generated
with the indicated Val–Phe residues (P2 and P1 sites of the
putative proteolysis site) changed to Lys–Lys (Fig. 4A),
amino acids that strongly inhibit cleavage by the HIV-1 PR
(Rognvaldsson and You, 2004). In addition, we generated
C-terminally truncated (DC) expression vectors by inserting
a stop codon immediately following the indicated Phe (Fig.4A). 293T cells were transiently transfected with the
respective kinase expression vectors with or without HIV-
1NL4-3 proviral DNA. In contrast to WT NDR1 and NDR2,
the mutant NDR1 and NDR2 kinases were not processed in
HIV-1-expressing cells (Fig. 4B). Furthermore, Western blot
analysis demonstrated that the mobility of the truncated
NDR1 and NDR2 proteins matched that of the PR-
processed forms (Fig. 4C). Taken together, these results
indicate the HIV-1 PR cleaves NDR1 and NDR2 at Phe440
and Phe438, respectively, as shown in Fig. 4A.
To explore potential functional consequences of PR
cleavage, we analyzed the subcellular localizations of full-
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previous findings (Devroe et al., 2004), NDR1 accumulated
in the nucleus (Fig. 4D, panel a), whereas NDR2 was
restricted to the cytoplasm (panel c). The localization of
NDR1DC was indistinguishable from that of WT NDR1
(compare panels a and b). However, C-terminal truncation
dramatically altered the subcellular distribution of NDR2
(panel d). Specifically, NDR2DC accumulated in the
nucleus (panel d) in a pattern similar to WT (panel a) or
NDR1DC (panel b). Similar results were obtained with
green fluorescent protein (GFP)-tagged NDR1 and NDR2
(data not shown).
To determine whether C-terminal truncation affects
NDR1 or NDR2 kinase activity, we purified the FLAG-
tagged kinases from 293T cells co-expressing GFP-Mob2.
We have previously shown that Mob2 forms a heterodimer
with the NDR kinases, an association that dramatically
stimulates NDR1 and NDR2 auto- and transphosphorylation
activity (Devroe et al., 2004). Truncation of NDR1 and
NDR2 did not inhibit their association with Mob2 or reduce
their autophosphorylation activity (Fig. 4E). However, C-
terminal truncation inhibited the ability of NDR1 and NDR2
to transphosphorylate heterologous substrates such as myelin
basic protein (Fig. 4E). Kinase reactions utilizing an NDR1/2
peptide substrate yielded similar results (data not shown).
Thus, C-terminal truncation at the HIV-1 PR cleavage site
altered the subcellular localization of NDR2 and modified
the enzymatic activity of both NDR1 and NDR2.Discussion
Prior to these studies, HIV-1 particles were known to
contain at least three cellular serine-threonine kinases:
ERK2/MAPK (Cartier et al., 1997; Jacque et al., 1998),
C-PKA (Cartier et al., 2003), and an unidentified ~53 kDa
kinase (Cartier et al., 1997, 1999). Here, we have expanded
this list to include the NDR1 and NDR2 kinases and have
demonstrated that the HIV-1 PR cleaves these kinases both
within virus particles and within producer cells.
In the current work, we have employed the subtilisin
digestion assay to recover microvesicle-free preparations of
HIV-1 derived from T-cells (HIV-1IIIB and HIV-1MN) and
293T cells (HIV-1NL4-3). Using a monoclonal antibody
capable of detecting NDR1, we have shown that endoge-
nous NDR1 is indeed incorporated into HIV-1 particles.
Subsequently, we employed FLAG-tagged expression vec-
tors to determine that the related NDR2 kinase is incorpo-
rated into HIV-1 particles as efficiently as NDR1. These
analyses also revealed that the HIV-1 PR cleaves both
kinases, a conclusion supported by four independent lines of
evidence. First, NDR1 and NDR2 processing is only
observed upon expression of WT, but not PR-defective,
HIV-1 (Fig. 3A). Second, two different small molecule
inhibitors of the HIV-1 PR completely block processing of
NDR1 and NDR2 (Figs. 3B and C, and data not shown).Third, a candidate cleavage site was identified near the C-
termini of NDR1 and NDR2, and mutations designed to
disrupt this cleavage site completely inhibit processing
(Figs. 4A and B). Finally, NDR1 and NDR2 truncated at the
identified cleavage site exhibit an electrophoretic mobility
consistent with that of the processed forms of NDR1 and
NDR2 (Fig. 4C). We note that although PR-processed forms
of NDR1 and NDR2 are observed both within producer cell
and virion lysates, PR processing is not required for
incorporation into virus particles (Fig. 3C).
An important future direction will be to determine
whether intravirion NDR1 and NDR2 kinases function to
phosphorylate viral or host cell-derived proteins. Such
intravirion modifications could have important functional
consequences aside from those traditionally associated with
phosphorylation (for example, alteration of subcellular
localization or protein–protein interactions). It has been
shown that serine phosphorylation within an HIV-1 PR
substrate cleavage site can significantly inhibit proteolysis
(Tozser et al., 1999). The presence of serine-threonine
kinases within HIV-1 particles may thus inhibit or prevent
proteolytic processing of various viral or nonviral PR
substrates, as previously suggested (Tozser et al., 1999).
Modulation of such PR substrates by virion-incorporated
NDR1, NDR2, ERK2/MAPK, or C-PKA might therefore
play important roles in HIV-1 replication.
Aside from identifying new virion-associated kinases,
our studies uncovered novel mechanisms by which HIV-1
effects the intracellular environment of its host cells. Despite
sharing ~87% sequence identity, NDR2 predominantly
localizes to the cytoplasm whereas NDR1 accumulates
within the nucleus (Devroe et al., 2004; Stegert et al., 2004).
Given that NDR2 contains only a single conservative
change (Arg to Lys) in the sequence defined as the NDR1
nuclear localization signal (Devroe et al., 2004; Millward et
al., 1995), the basis for this differential localization remains
unknown. Our current work suggests that HIV-1 PR
cleavage effects NDR2 subcellular localization, since
NDR2 truncated at the PR cleavage site accumulates within
the nucleus. This observation implies NDR2 residues 439–
464 include a determinant responsible for its cytoplasmic
distribution or nuclear exclusion. In contrast, HIV-1 PR
cleavage does not affect the localization of NDR1, since
NDR1 truncated at the PR cleavage site exhibits an
intracellular distribution indistinguishable from that of WT
NDR1.
In addition to modifying the intracellular distribution of
NDR2 kinase, PR cleavage of the cell-associated NDR
kinases might alter their enzymatic activity or substrate
specificity. Indeed, the PR cleavage site is located at the
beginning of a conserved hydrophobic motif containing a
phosphoaccepting Thr residue reportedly critical for NDR1
and NDR2 activity (Millward et al., 1999; Stegert et al.,
2004). In vitro studies using purified full-length and
truncated kinases indicate PR cleavage inhibits NDR trans-
phosphorylation of a generic kinase substrate (Fig. 4E).
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inhibits general NDR transphosphorylation activity or that it
significantly alters NDR substrate specificity. Interestingly,
truncation does not appear to affect NDR1 or NDR2
autophosphorylation, which suggests that the PR-processed
forms retain at least some enzymatic activity. Furthermore,
NDR1 and NDR2 truncated at the HIV-1 PR cleavage site
can efficiently bind their kinase activating partner Mob2
(Fig. 4E) (Devroe et al., 2004), which is consistent with a
recent report that implicates the N-termini of the NDR
kinases as important for Mob binding (Bichsel et al., 2004).
Additional experiments will be necessary to determine
whether the PR-processed kinases are completely unable
to transphosphorylate heterologous proteins, retain the
ability to phosphorylate certain NDR substrates, or gain
the ability to phosphorylate substrates not normally phos-
phorylated by full-length NDR1 and NDR2. Such findings
could advance our understanding of how HIV-1 infection
effects the signaling environment of the host cell.
Aside from HIV-1, we determined that endogenous
NDR1 is incorporated into subtilisin-digested preparations
of human T-cell lymphotrophic virus type 1 and avian
myeoblastoma virus, yet we were unable to detect endog-
enous NDR1 in purified Moloney murine leukemia virus
particles (data not shown). Given their incorporation into
HIV-1 and a subset of other retroviral particles, it is
tempting to speculate that NDR1 or NDR2 may play an
important role in the viral life cycle, as has been suggested
for HIV-associated ERK2/MAPK and C-PKA (Cartier et al.,
2003; Hemonnot et al., 2004; Jacque et al., 1998).
Preliminary experiments with stable NDR1 and NDR2
bknock-downQ cell lines did not reveal a dramatic defect in
viral replication (data not shown). Since such experiments
yield only a partial ablation of NDR expression, more robust
and specific methods of inhibition will need to be employed.
The development of knockout cell lines or specific small
molecule inhibitors should shed light on the potential role of
NDR kinases in HIV-1 replication.Materials and methods
Cells, protein extraction, and Western blot analysis
293T, HeLa, and HeLa-CD4 cells were grown in DMEM
(Invitrogen) containing 10% fetal bovine serum and
penicillin/streptomycin. Protein lysates were prepared in
20 mM HEPES pH 7.5, 150 mM NaCl, 1% sodium
deoxycholate, 1% Nonidet P40 (NP-40), 0.1% sodium
dodecyl sulfate (SDS), 2 mM ethylenediaminetetraacetic
acid (EDTA), containing Complete Protease Inhibitors
(Roche Molecular Biochemicals). Protein concentration
was determined with the BioRad DC Assay kit (BioRad
Laboratories). Western blotting was performed as described
(Devroe and Silver, 2002). When indicated, extracts were
incubated for 15 min at 30 8C in 50 mM Tris pH 7.5, 1 mMMgCl2, containing 30 U of CIP (New England Biolabs)
prior to Western blotting. Antibodies used in this study
include monoclonal anti-NDR1 and anti-CD45 (Trans-
duction Laboratories), monoclonal anti-FLAG M2 (Sigma),
monoclonal anti-gp41 2F5 (Purtscher et al., 1994) (obtained
from Hermann Katinger through the NIH AIDS Research
and Reference Reagent Program), polyclonal anti-CA
(Advanced Biotechnologies Inc.), and polyclonal anti-green
fluorescent protein (GFP) (Seedorf et al., 1999). HRP-
conjugated secondary antibodies were from Jackson Immu-
noResearch Laboratories.
Viruses, virion production, and purification
Sucrose gradient-purified HIV-1IIIB and HIV-1MN were
purchased from Advanced Biotechnologies Inc. Molecular
clones used in this study included HIV-1-based pNL43/
XmaI (Brown et al., 1999), HXBH10/R+ and HXBH10/R+/
PR (Bukovsky and Gottlinger, 1996) (gift of Heinrich
Gottlinger). Virus stocks were produced by transient trans-
fection of 293T cells with DNA in the presence of calcium
phosphate. When indicated, transfections were performed in
the presence of 5 AM Nelfinavir or Saquinvair (both from
the AIDS Research and Reference Reagent Program) or the
dimethyl sulfoxide (DMSO) diluent.
Digestion with subtilisin (Sigma) was performed essen-
tially as previously described (Gurer et al., 2002; Ott et al.,
1995). Briefly, cell-free supernatants from transiently trans-
fected cells were layered onto 6 ml 25% sucrose (w/v)
prepared in 10 mM Tris pH 8.0, 100 mM NaCl, 1 mM
EDTA (TNE), and centrifuged for 2 h at 4 8C at 27000 rpm
in a SW28 rotor. The pelleted material was resuspended in
900 Al 10 mM Tris pH 8.0, 100 mM NaCl (TN), and
incubated at 37 8C overnight following addition of 900 Al
subtilisin diluted in 2 digestion buffer (40 mM Tris pH
8.0, 2 mM CaCl2). Reactions were stopped via addition of 1
mM phenylmethylsulfonyl fluoride (PMSF) (Sigma) and
incubated for 20 min at room temperature. Finally, the
samples were diluted in TNE (10 ml final volume), layered
onto a 6 ml 25% sucrose cushion, and centrifuged as above.
Pelleted material was resuspended in 2 SDS sample buffer
containing 1 mM PMSF. When indicated, pelleted virions
were first resuspended in ~350 Al TN, then disrupted via
addition of NP-40 to 0.5%, followed by three rounds of
rapid freezing and thawing. After the final thaw, the
disrupted virions were diluted to 900 Al in TN and digested
as above; total protein was recovered by methanol–chloro-
form–water precipitation as previously described (Chen et
al., 1999; Wessel and Flugge, 1984) and resuspended in 2
SDS sample buffer containing 1 mM PMSF.
Analysis of NDR1 and NDR2 localization and activity
pFLAG-NDR1, pFLAG-NDR2, and pGFP-Mob2 vec-
tors have been previously described (Devroe et al., 2004).
To generate pFLAG-NDR1DC and pFLAG-NDR2DC, we
E. Devroe et al. / Virology 331 (2005) 181–189188employed the QuickChange Mutagenesis Kit (Stratagene)
and oligonucleotides that introduced a stop (TGA) codon at
the putative PR cleavage site. The PRres expression
constructs were similarly generated using the QuickChange
Mutagenesis Kit and oligonucleotides that altered the
indicated Val–Phe codons to Lys–Lys. HeLa-CD4 cells
were transiently transfected using FuGENE 6 transfection
reagent (Roche Molecular Biochemicals) and monitored by
indirect immunofluorescence microscopy using a DeltaVi-
sion platform (Applied Precision Inc.) as previously
described (Devroe et al., 2004). Kinase purification and
assays were performed as previously described (Devroe et
al., 2004).
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